Hitesh Mistry

The University of Manchester

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Cancer Biology Cancer Biology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (25)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (18)

Frank Kloprogge

UNITED KINGDOM

View details

Tim Smith

Senior Lecturer

Bangor University

UNITED KINGDOM

View details

Tim Illidge

The University of Manchester

UNITED KINGDOM

View details

Fiona Blackhall

The University of Manchester

UNITED KINGDOM

View details

Parmesh Gajjar

Chief Technology Officer

Infex Therapeutics

UNITED KINGDOM

View details

Peter Hoskin

The University of Manchester

UNITED KINGDOM

View details

Esther Baena

The University of Manchester

UNITED KINGDOM

View details

James O'Connor

Professor and Team Leader

Institute of Cancer Research

UNITED KINGDOM

View details

Robert Bristow

The University of Manchester

UNITED KINGDOM

View details

Ann Henry

Associate Professor in Clinical Oncology

University of Leeds School of Medicine

UNITED KINGDOM

View details

robert metcalf

The University of Manchester

UNITED KINGDOM

View details

Kayode Ogungbenro

Lecturer

The University of Manchester

UNITED KINGDOM

View details

Ananya Choudhury

The University of Manchester

UNITED KINGDOM

View details

Corinne Faivre-Finn

The University of Manchester

UNITED KINGDOM

View details

David Woolf

Honorary Senior Lecturer

University of Manchester

UNITED KINGDOM

View details

Catharine West

The University of Manchester

UNITED KINGDOM

View details

Leon Aarons

The University of Manchester

UNITED KINGDOM

View details

Lee Malcomson

The University of Manchester

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hitesh Mistry

Research Interests

Explore related searches

Contact this professor

Articles (25)

The effect of time from surgery to commencing adjuvant radiotherapy for patients with head and neck squamous cell carcinoma

KDM6A, ARID1A and SETD2 loss-of-function mutations as prognostic biomarkers and their association with sites of metastatic progression in locally-advanced, recurrent or metastatic adenoid cystic carcinoma

A Pharmacokinetic and Pharmacodynamic Model of an IL-12 Anchored-Drug Conjugate for the Treatment of Solid Tumors

A Multiple-Model-Informed Drug-Development Approach for Optimal Regimen Selection of an Oncolytic Virus in Combination With Pembrolizumab

Machine Learning and Artificial Intelligence in <scp>PK‐PD</scp> Modeling: Fad, Friend, or Foe?

Tale of two zones: investigating the clinical outcomes and research gaps in peripheral and transition zone prostate cancer through a systematic review and meta-analysis

Randomized Phase 3 Trial of the Hypoxia Modifier Nimorazole Added to Radiation Therapy With Benefit Assessed in Hypoxic Head and Neck Cancers Determined Using a Gene Signature (NIMRAD)

A study demonstrating users’ preference for the adapted-REQUITE patient-reported outcome questionnaire over PRO-CTCAE in patients with lung cancer

Explaining in-vitro to in-vivo efficacy correlations in oncology pre-clinical development via a semi-mechanistic mathematical model

Tumour Size and Overall Survival in a Cohort of Patients with Unifocal Glioblastoma: A Uni- and Multivariable Prognostic Modelling and Resampling Study

A hypoxia biomarker does not predict benefit from giving chemotherapy with radiotherapy in the BC2001 randomised controlled trial

Long-term outcomes after concurrent once- or twice-daily chemoradiation in limited-stage small-cell lung cancer: a brief report from the CONVERT trial

Hierarchical cluster analysis and nonlinear mixed-effects modelling for candidate biomarker detection in preclinical models of cancer.

Hypoxia-associated gene signatures are not prognostic in high-risk localised prostate cancers undergoing androgen deprivation therapy with radiotherapy

Training and external validation of pre-treatment FDG PET-CT-based models for outcome prediction in anal squamous cell carcinoma

Association between radiotherapy protocol variations and outcome in the CONVERT trial

Bladder-Sparing Treatment With Radical Dose Radiotherapy Is an Effective Alternative to Radical Cystectomy in Patients With Clinically Node-Positive Nonmetastatic Bladder Cancer

Mixed effects modeling of radiotherapy in combination with immune checkpoint blockade or inhibitors of the DNA damage response pathway

Technical development and validation of a clinically applicable microenvironment classifier as a biomarker of tumour hypoxia for soft tissue sarcoma

Radiosensitivity Index (“RSI”) is not fit to be used for dose-adjustments: a pan-cancer analysis

Skipping a pillar does not make for strong foundations: Pharmacokinetic‐pharmacodynamic reasoning behind the shape of dose–response relationships in oncology

Pretreatment Lymphocyte Count Predicts Benefit From Concurrent Chemotherapy With Radiotherapy in Oropharyngeal Cancer

Determining bioequivalence possibilities of long acting injectables through population PK modelling

Using Real-world Data to Define a Validated Nomogram for Advanced Bladder Cancer Patients Who Respond to Immunotherapy

Clinico-pathological predictors of clinical complete response in rectal cancer

Collaborators (18)

Frank Kloprogge

Tim Smith

Tim Illidge

Fiona Blackhall

Parmesh Gajjar

Peter Hoskin

Esther Baena

James O'Connor

Robert Bristow

Ann Henry

robert metcalf

Kayode Ogungbenro

Ananya Choudhury

Corinne Faivre-Finn

David Woolf

Catharine West

Leon Aarons

Lee Malcomson

Make your next move.